196 related articles for article (PubMed ID: 30779243)
1. Investigation of human apoB48 metabolism using a new, integrated non-steady-state model of apoB48 and apoB100 kinetics.
Björnson E; Packard CJ; Adiels M; Andersson L; Matikainen N; Söderlund S; Kahri J; Sihlbom C; Thorsell A; Zhou H; Taskinen MR; Borén J
J Intern Med; 2019 May; 285(5):562-577. PubMed ID: 30779243
[TBL] [Abstract][Full Text] [Related]
2. Apolipoprotein B48 metabolism in chylomicrons and very low-density lipoproteins and its role in triglyceride transport in normo- and hypertriglyceridemic human subjects.
Björnson E; Packard CJ; Adiels M; Andersson L; Matikainen N; Söderlund S; Kahri J; Hakkarainen A; Lundbom N; Lundbom J; Sihlbom C; Thorsell A; Zhou H; Taskinen MR; Borén J
J Intern Med; 2020 Oct; 288(4):422-438. PubMed ID: 31846520
[TBL] [Abstract][Full Text] [Related]
3. Effects of Evolocumab on the Postprandial Kinetics of Apo (Apolipoprotein) B100- and B48-Containing Lipoproteins in Subjects With Type 2 Diabetes.
Taskinen MR; Björnson E; Kahri J; Söderlund S; Matikainen N; Porthan K; Ainola M; Hakkarainen A; Lundbom N; Fermanelli V; Fuchs J; Thorsell A; Kronenberg F; Andersson L; Adiels M; Packard CJ; Borén J
Arterioscler Thromb Vasc Biol; 2021 Feb; 41(2):962-975. PubMed ID: 33356392
[TBL] [Abstract][Full Text] [Related]
4. Postprandial accumulation of chylomicrons and chylomicron remnants is determined by the clearance capacity.
Adiels M; Matikainen N; Westerbacka J; Söderlund S; Larsson T; Olofsson SO; Borén J; Taskinen MR
Atherosclerosis; 2012 May; 222(1):222-8. PubMed ID: 22365426
[TBL] [Abstract][Full Text] [Related]
5. Effects of liraglutide on the metabolism of triglyceride-rich lipoproteins in type 2 diabetes.
Taskinen MR; Björnson E; Matikainen N; Söderlund S; Pietiläinen KH; Ainola M; Hakkarainen A; Lundbom N; Fuchs J; Thorsell A; Andersson L; Adiels M; Packard CJ; Borén J
Diabetes Obes Metab; 2021 May; 23(5):1191-1201. PubMed ID: 33502078
[TBL] [Abstract][Full Text] [Related]
6. Hypothesis II: The majority of VLDL-apoB48 remnants in postprandial plasma are derived from the liver, not from the intestine.
Nakajima K; Tokita Y; Tanaka A
Clin Chim Acta; 2019 Mar; 490():12-16. PubMed ID: 30553860
[TBL] [Abstract][Full Text] [Related]
7. Postprandial metabolism of apolipoproteins B48, B100, C-III, and E in humans with APOC3 loss-of-function mutations.
Taskinen MR; Björnson E; Matikainen N; Söderlund S; Rämö J; Ainola MM; Hakkarainen A; Sihlbom C; Thorsell A; Andersson L; Bergh PO; Henricsson M; Romeo S; Adiels M; Ripatti S; Laakso M; Packard CJ; Borén J
JCI Insight; 2022 Oct; 7(19):. PubMed ID: 36040803
[TBL] [Abstract][Full Text] [Related]
8. Contribution of intestinal triglyceride-rich lipoproteins to residual atherosclerotic cardiovascular disease risk in individuals with type 2 diabetes on statin therapy.
Taskinen MR; Matikainen N; Björnson E; Söderlund S; Inkeri J; Hakkarainen A; Parviainen H; Sihlbom C; Thorsell A; Andersson L; Adiels M; Packard CJ; Borén J
Diabetologia; 2023 Dec; 66(12):2307-2319. PubMed ID: 37775612
[TBL] [Abstract][Full Text] [Related]
9. Effects of TM6SF2 E167K on hepatic lipid and very low-density lipoprotein metabolism in humans.
Borén J; Adiels M; Björnson E; Matikainen N; Söderlund S; Rämö J; Ståhlman M; Ripatti P; Ripatti S; Palotie A; Mancina RM; Hakkarainen A; Romeo S; Packard CJ; Taskinen MR
JCI Insight; 2020 Dec; 5(24):. PubMed ID: 33170809
[TBL] [Abstract][Full Text] [Related]
10. Apolipoprotein B: a clinically important apolipoprotein which assembles atherogenic lipoproteins and promotes the development of atherosclerosis.
Olofsson SO; Borèn J
J Intern Med; 2005 Nov; 258(5):395-410. PubMed ID: 16238675
[TBL] [Abstract][Full Text] [Related]
11. Omega 3 Improves Both apoB100-containing Lipoprotein Turnover and their Sphingolipid Profile in Hypertriglyceridemia.
Ferchaud-Roucher V; Zair Y; Aguesse A; Krempf M; Ouguerram K
J Clin Endocrinol Metab; 2020 Oct; 105(10):. PubMed ID: 32805740
[TBL] [Abstract][Full Text] [Related]
12. Model development to describe the heterogeneous kinetics of apolipoprotein B and triglyceride in hypertriglyceridemic subjects.
Barrett PH; Baker N; Nestel PJ
J Lipid Res; 1991 May; 32(5):743-62. PubMed ID: 2072038
[TBL] [Abstract][Full Text] [Related]
13. Effect of insulin therapy on metabolic fate of apolipoprotein B-containing lipoproteins in NIDDM.
Taskinen MR; Packard CJ; Shepherd J
Diabetes; 1990 Sep; 39(9):1017-27. PubMed ID: 2200727
[TBL] [Abstract][Full Text] [Related]
14. Apolipoprotein B48, the Structural Component of Chylomicrons, Is Sufficient to Antagonize Staphylococcus aureus Quorum-Sensing.
Elmore BO; Triplett KD; Hall PR
PLoS One; 2015; 10(5):e0125027. PubMed ID: 25942561
[TBL] [Abstract][Full Text] [Related]
15. Minor Contribution of Endogenous GLP-1 and GLP-2 to Postprandial Lipemia in Obese Men.
Matikainen N; Björnson E; Söderlund S; Borén C; Eliasson B; Pietiläinen KH; Bogl LH; Hakkarainen A; Lundbom N; Rivellese A; Riccardi G; Després JP; Alméras N; Holst JJ; Deacon CF; Borén J; Taskinen MR
PLoS One; 2016; 11(1):e0145890. PubMed ID: 26752550
[TBL] [Abstract][Full Text] [Related]
16. Metabolic basis of hypotriglyceridemic effects of insulin in normal men.
Malmström R; Packard CJ; Watson TD; Rannikko S; Caslake M; Bedford D; Stewart P; Yki-Järvinen H; Shepherd J; Taskinen MR
Arterioscler Thromb Vasc Biol; 1997 Jul; 17(7):1454-64. PubMed ID: 9261280
[TBL] [Abstract][Full Text] [Related]
17. Basal and insulin-regulated VLDL1 and VLDL2 kinetics in men with type 2 diabetes.
Johansen RF; Søndergaard E; Sørensen LP; Jurik AG; Christiansen JS; Nielsen S
Diabetologia; 2016 Apr; 59(4):833-43. PubMed ID: 26781548
[TBL] [Abstract][Full Text] [Related]
18. Effects of insulin and acipimox on VLDL1 and VLDL2 apolipoprotein B production in normal subjects.
Malmström R; Packard CJ; Caslake M; Bedford D; Stewart P; Yki-Järvinen H; Shepherd J; Taskinen MR
Diabetes; 1998 May; 47(5):779-87. PubMed ID: 9588450
[TBL] [Abstract][Full Text] [Related]
19. In vivo studies of VLDL metabolism and LDL heterogeneity.
Demant T; Packard C
Eur Heart J; 1998 Jul; 19 Suppl H():H7-10. PubMed ID: 9717058
[TBL] [Abstract][Full Text] [Related]
20. Kinetic and Related Determinants of Plasma Triglyceride Concentration in Abdominal Obesity: Multicenter Tracer Kinetic Study.
Borén J; Watts GF; Adiels M; Söderlund S; Chan DC; Hakkarainen A; Lundbom N; Matikainen N; Kahri J; Vergès B; Barrett PH; Taskinen MR
Arterioscler Thromb Vasc Biol; 2015 Oct; 35(10):2218-24. PubMed ID: 26315407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
